Royalty Pharma plc is a healthcare company.
Royalty Pharma plc (RPRX) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 07:32 ET. Consensus EPS estimate is $1.18.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | Jun 2026 qtr | $1.27 | $1.32 | +3.9% | $773.00M |
| 2026-05-06 | Mar 2026 qtr | $1.21 | $1.30 | +7.4% | $925.00M |
| 2026-02-11 | Dec 2025 qtr | $1.29 | $1.46 | +13.2% | $874.00M |
| 2025-11-05 | Sep 2025 qtr | $0.99 | $1.17 | — | $609.29M |
| 2025-08-06 | Jun 2025 qtr | $1.03 | $1.14 | +10.7% | $578.66M |
| 2025-05-08 | Mar 2025 qtr | $0.95 | $1.06 | +11.2% | $568.25M |
| 2025-02-11 | Dec 2024 qtr | $0.99 | $1.15 | — | $594.00M |
| 2024-11-06 | Sep 2024 qtr | $0.93 | $1.04 | +12.1% | $564.69M |
RPRX has beaten consensus EPS in 6 of its last 6 scored quarters.
RPRX pays a quarterly dividend, currently yielding 1.58%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-14 | $0.235 | 2026-09-10 |
| 2026-05-15 | $0.235 | 2026-06-10 |
| 2026-02-20 | $0.235 | 2026-03-10 |
| 2025-11-14 | $0.22 | 2025-12-10 |
| 2025-08-15 | $0.22 | 2025-09-10 |
| 2025-05-16 | $0.22 | 2025-06-10 |